ACLX · Arcellx, Inc.

$115.07 +0.00 (+0.00%) At close · Apr 29

Market Cap

$6.73B

58.48M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rami Elghandour	CEO	$653,288	$546,000	$9,342,069	$10,850,151	—	$11,160	$21,402,668
Michelle Gilson	CFO	$475,960	$299,250	$3,452,495	$4,009,849	—	$10,782	$8,248,336
Christopher Heery	Chief Medical Officer	$480,960	$302,400	$2,193,387	$2,547,422	—	$11,160	$5,535,329

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rami Elghandour	CEO	$600,960	$330,000	$18,754,302	$5,268,334	—	$10,710	$24,964,306
Christopher Heery	Chief Medical Officer	$480,960	$192,000	$1,537,785	$1,639,028	—	$10,440	$3,860,213
Michelle Gilson	CFO	$416,464	$176,000	$1,427,939	$1,521,951	—	$10,332	$3,552,686

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rami Elghandour	CEO	$565,000	$450,588	$3,757,693	$9,337,815	—	$9,150	$14,120,145
Christopher Heery	Chief Medical Officer	$430,000	$249,400	$1,207,161	$3,019,271	—	$9,150	$4,914,982
Michelle Gilson	CFO	$256,308	$243,600	$582,688	$1,031,721	—	$167,831	$2,114,317

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rami Elghandour	CEO	$470,272	$325,000	$10,300,000	$12,299,542	—	$8,700	$23,403,514
Christopher Heery	Chief Medical Officer	$295,336	$227,539	—	$1,535,520	—	$8,700	$2,067,095
Michelle Gilson	CFO	—	—	—	—	—	—	—

Key facts CIK 1786205 CUSIP 03940C100 13F (30d) 2 filings 2 filers Visit website Investor relations